Animal health company Elanco (NYSE:ELAN) reported Q1 CY2025 results , but sales were flat year on year at $1.19 billion. The company’s full-year revenue guidance of $4.55 billion at the midpoint ...

Elanco Animal Health Inc.’s stock was headed for an 18-month high on Monday after the company said it has agreed to sell its aqua business to Merck Animal Health for $1.3 billion in cash, in a ...

After an acquisition of Bayer Animal Health in 2020, Elanco has made progress in paying down debt. Robust pipeline with six potential blockbuster products to be launched in 2024 and 2025.

Elanco Animal Health Inc. said Monday it plans to restructure operations, which will result in the loss of 420 jobs. The Greenfield-based maker of vaccines, antibiotics and other animal-health ...